Biopsy Needle Manufacturing and Supply

The contract involves the manufacture, quality assurance, packaging, labeling, and delivery of biopsy needles identified by NSN 6515-01-488-8392, all of which must fully comply with detailed technical specifications set by the Defense Logistics Agency and meet strict military packaging standards. The work requires adherence to rigorous quality controls throughout production to ensure reliability and performance in clinical and field environments, with final products subject to inspection and certification prior to delivery. All packaging and labeling must conform to Department of Defense requirements for identification, traceability, and durability under storage and transport conditions. The solicitation is structured as a subcontract under the NAICS code 339112, indicating the focus on medical equipment and supplies manufacturing, and is managed by the Medical Supply Chain MD Surg FSF under the Department of Defense. The opportunity was posted on July 21, 2026, with a firm deadline for responses set for July 27, 2026, providing a limited window for qualified manufacturers to submit proposals. While specific performance location and point of contact details are not provided, the contract will be administered through the DLA’s DIBBS system, and successful bidders will be expected to fulfill the full scope of supply chain responsibilities from production to delivery without deviations from the mandated technical and regulatory standards.